Essays On Real Assets, Corporate Investment and Equity Financing: Evidence from U.S. Capital Markets and Securitized Real Estate

Ph.DDOCTOR OF PHILOSOPH

An acousto-optic modulator based bi-frequency interferometer for quantum technology

Acousto-optic modulators (AOMs) have been widely used in quantum optical technology, but the non-ideal diffraction efficiency limits its application in a quantum system. Here we demonstrate a bi-frequency interferometer using AOMs as both the beam-splitter and the beam-combiner. The intensity of the input light can be as low as the single photon level, and the interferometer can work in a chopped phase locking mode. The modulation for the phase locking scheme is realized on the beam-splitting AOM driven by specially designed radio frequency signal, which avoids using extra optical modulators and makes the quantum efficiency of the system as high as $(95\pm1)\%$. By optimizing the factors that affect the mode matching, the visibility of the beating signal for the interferometer is $(99.5\pm0.2)\%$. This near prefect visibility allows the interferometer to be applied in high efficiency quantum technical schemes while leaving the diffraction efficiencies of each AOM for about $50\%$. This greatly reduced the demand for the driving of AOMs.Comment: 6 pages, 4 figure

Ginkgolide K potentiates the protective effect of ketamine against intestinal ischemia/reperfusion injury by modulating NF-κB/ERK/JNK signaling pathway

Purpose: To investigate the effect of ginkgolide K and ketamine treatments, alone and in combination, on intestinal  ischemia/reperfusion injury (I/R)-induced injury in rats, as well as the mechanism involved. Methods: Rats were treated with ginkgolide K (GK, 15 mg/kg i.v) and ketamine (KTM, 100 mg/kg i.p.), either alone or in combination 30 min before the induction of intestinal I/R. The effects of GK and KTM were determined by assessing the levels of cytokines in serum, and parameters of oxidative stress and ROS production in the intestinal tissues of I/R rats. Moreover, intestinal mRNA expressions of JNK, ERK, p38 and NF-kB were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Results: GK and KTM treatments, alone and in combination, reduced cytokine levels in serum and oxidative stress parameters in intestinal tissues, when compared to I/R group of rats. Treatments with GK and KTM, alone and in combination, mitigated the altered mRNA expressions of JNK, ERK, p38 and NF-kB in intestinal tissues of I/R-injured rats. Conclusion: These results reveal that GK potentiates the protective effect of KTM100 on I/R-induced intestinal injury in rats by regulating the NF-kB/ERK/JNK signaling pathway. Therefore, GK and KTM may find use in the management of I/R Keywords: Ginkgolide K, Ketamine, Intestinal injury, Ischemia/Reperfusion, Inflammatio

Rapid Estimation of Binding Activity of Influenza Virus Hemagglutinin to Human and Avian Receptors

A critical step for avian influenza viruses to infect human hosts and cause epidemics or pandemics is acquisition of the ability of the viral hemagglutinin (HA) to bind to human receptors. However, current global influenza surveillance does not monitor HA binding specificity due to a lack of rapid and reliable assays. Here we report a computational method that uses an effective scoring function to quantify HA-receptor binding activities with high accuracy and speed. Application of this method reveals receptor specificity changes and its temporal relationship with antigenicity changes during the evolution of human H3N2 viruses. The method predicts that two amino acid differences at 222 and 225 between HAs of A/Fujian/411/02 and A/Panama/2007/99 viruses account for their differences in binding to both avian and human receptors; this prediction was verified experimentally. The new computational method could provide an urgently needed tool for rapid and large-scale analysis of HA receptor specificities for global influenza surveillance.National Key Project (2008ZX10004-013)National Institutes of Health (U.S.) (grant AI07443)Singapore-MIT Alliance for Research and TechnologyMassachusetts Institute of Technology. International Science and Technology Initiatives Global Seed FundNational Basic Research Program (973 Program) (2009CB918503)National Basic Research Program (973 Program) (2006CB911002

Amplification Refractory Mutation System (ARMS)-PCR for waxy sorghum authentication with single-nucleotide resolution

Waxy sorghum has greater economic value than wild sorghum in relation to their use in food processing and the brewing industry. Thus, the authentication of the waxy sorghum species is an important issue. Herein, a rapid and sensitive Authentication Amplification Refractory Mutation System-PCR (aARMS-PCR) method was employed to identify sorghum species via its ability to resolve single-nucleotide in genes. As a proof of concept, we chose a species of waxy sorghum containing the wxc mutation which is abundantly used in liquor brewing. The aARMS-PCR can distinguish non-wxc sorghum from wxc sorghum to guarantee identification of specific waxy sorghum species. It allowed to detect as low as 1% non-wxc sorghum in sorghum mixtures, which ar one of the most sensitive tools for food authentication. Due to its ability for resolving genes with single-nucleotide resolution and high sensitivity, aARMS-PCR may have wider applicability in monitoring food adulteration, offering a rapid food authenticity verification in the control of adulteration

Improved breast lesion detection in mammogram images using a deep neural network

PURPOSEThis study aimed to investigate the effect of using a deep neural network (DNN) in breast cancer (BC) detection.METHODSIn this retrospective study, a DNN-based model was constructed from a total of 880 mammograms that 220 patients underwent between April and June 2020. The mammograms were reviewed by two senior and two junior radiologists with and without the aid of the DNN model. The performance of the network was assessed by comparing the area under the curve (AUC) and receiver operating characteristic curves for the detection of four features of malignancy (masses, calcifications, asymmetries, and architectural distortions), with and without the aid of the DNN model and by the senior and junior radiologists. Additionally, the effect of utilizing the DNN on diagnosis time for both the senior and junior radiologists was evaluated.RESULTSThe AUCs of the model for the detection of mass and calcification were 0.877 and 0.937, respectively. In the senior radiologist group, the AUC values for evaluation of mass, calcification, and asymmetric compaction were significantly higher with the DNN model than those obtained without the model. Similar effects were observed in the junior radiologist group, but the increase in the AUC values was even more dramatic. The median mammogram assessment time of the junior and senior radiologists was 572 (357–951) s, and 273.5 (129–469) s, respectively, with the DNN model, and the corresponding assessment time without the model, was 739 (445–1003) s and 321 (195–491) s, respectively.CONCLUSIONThe DNN model exhibited high accuracy in detecting the four named features of BC and effectively shortened the review time by both senior and junior radiologists

Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases

<p>Abstract</p> <p>Objective</p> <p>To determine plasma apolipoprotein M (apoM) levels and other lipid profiles in hepatocellular carcinoma (HCC) patients compared to other chronic liver diseases and normal subjects.</p> <p>Materials and methods</p> <p>36 HCC, 68 chronic hepatitis, 29 liver cirrhosis patients and 64 normal controls were subjected in the present study. Serum lipids, lipoproteins, apolipoprotein AI (apoAI) and apoB were determined by the conventional methods. Plasma apoM levels were semi-quantitatively determined by both dot-blotting and western blotting analysis.</p> <p>Results</p> <p>Serum levels of triglycerides (TG), HDL-cholesterol, apoAI and lipoprotein (a) (Lp(a)) were significantly lower in the HCC patients than in the normal subjects, whereas there were no obvious differences on serum total cholesterol, LDL-cholesterol and apoB between HCC patients and normal subjects. However, plasma apoM levels in HCC patients were significantly increased than those in the normal subjects, but lower than those in the chronic hepatitis and cirrhosis patients.</p> <p>Conclusion</p> <p>It is concluded that serum TG, apoAI, HDL-C and Lp(a) were significantly decreased in HCC patients than in controls, whereas plasma apoM levels were significantly increased in the HCC patients. Decreased serum TG, apoAI, HDL-C and Lp(a) may reflect the liver damage in HCC patients, whereas the clinical significance of increased plasma apoM levels in relation to HCC is not clear.</p

An In Vivo Screen Identifies PYGO2 as a Driver for Metastatic Prostate Cancer

Advanced prostate cancer displays conspicuous chromosomal instability and rampant copy number aberrations, yet the identity of functional drivers resident in many amplicons remain elusive. Here, we implemented a functional genomics approach to identify new oncogenes involved in prostate cancer progression. Through integrated analyses of focal amplicons in large prostate cancer genomic and transcriptomic datasets as well as genes upregulated in metastasis, 276 putative oncogenes were enlisted into an in vivo gain-of-function tumorigenesis screen. Among the top positive hits, we conducted an in-depth functional analysis on Pygopus family PHD finger 2 (PYGO2), located in the amplicon at 1q21.3. PYGO2 overexpression enhances primary tumor growth and local invasion to draining lymph nodes. Conversely, PYGO2 depletion inhibits prostate cancer cell invasion in vitro and progression of primary tumor and metastasis in vivo In clinical samples, PYGO2 upregulation associated with higher Gleason score and metastasis to lymph nodes and bone. Silencing PYGO2 expression in patient-derived xenograft models impairs tumor progression. Finally, PYGO2 is necessary to enhance the transcriptional activation in response to ligand-induced Wnt/β-catenin signaling. Together, our results indicate that PYGO2 functions as a driver oncogene in the 1q21.3 amplicon and may serve as a potential prognostic biomarker and therapeutic target for metastatic prostate cancer.Significance: Amplification/overexpression of PYGO2 may serve as a biomarker for prostate cancer progression and metastasis. Cancer Res; 78(14); 3823-33. ©2018 AACR